CHARLES RIV LAB INT (RV6 BE) stock market data APIs
€141.2976
-2.01(-1.4%)
as of November 18, 2025
Try our APIs with
free plan!
CHARLES RIV LAB INT Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for RV6.BE.
Prev. Close
141.2976
Open
139.2891
High
140.3055
Low
137.7984
52 wk Range
82.04-193.35
Market Cap
16 130 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CHARLES RIV LAB INT data using free add-ons & libraries
Get CHARLES RIV LAB INT Fundamental Data
CHARLES RIV LAB INT Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 2.34
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CHARLES RIV LAB INT News
New
Charles River (CRL) International Revenue Performance Explored
Have you evaluated the performance of Charles River Laboratories' (CRL) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of t...
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
WILMINGTON, Mass., November 17, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Global Healthcare Conference in ...
Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest
Looking back on drug development inputs & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers. Compani...
5 Must-Read Analyst Questions From Charles River Laboratories’s Q3 Earnings Call
Charles River Laboratories’ third quarter results were met with negative market reaction, as investors focused on the company’s muted top-line growth and margin pressures. Management cited ongoing...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
